Trends in first-line antiretroviral therapy in Asia: Results from the treat Asia HIV Observational Database

• Main Authors: Boettiger D.C., Kerr S., Ditangco R., Merati T.P., Pham T.T.T., Chaiwarith R., Kiertiburanakul S., Li C.K.P., Kumarasamy N., Vonthanak S., Lee C., Van Kinh N., Pujari S., Wong W.W., Kamarulzaman A., Zhang F., Yunihastuti E., Choi J.Y., Oka S., Ng O.T., Kantipong P., Mustafa M., Ratanasuwan W., Sohn A., Law M.
• Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
• Format: Article
• Published: 2019
• Subjects: abacavir; atazanavir; darunavir; didanosine; efavirenz; emtricitabine; fosamprenavir; Human immunodeficiency virus proteinase inhibitor; indinavir; lamivudine; lopinavir; nelfinavir; nevirapine; nonnucleoside reverse transcriptase inhibitor; raltegravir; rilpivirine; RNA directed DNA polymerase inhibitor; saquinavir; stavudine; tenofovir; tipranavir; zalcitabine; zidovudine; 2',3' dideoxynucleoside derivative; anti human immunodeficiency virus agent; adult; aging; antiretroviral therapy; antiviral therapy; Article; Asia; data base; drug safety; drug use; drug utilization; female; hepatitis C; human; Human immunodeficiency virus infection; major clinical study; male; observational study; prescription; primary health care; risk factor; sex difference; treatment failure; trend study; adverse drug reaction; adverse effects; classification; drug effects; highly active antiretroviral therapy; HIV Infections; Human immunodeficiency virus; pathology; procedures; virology; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Female; HIV; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161774
• Institution: National University of Singapore

10.1371/journal.pone.0106525